MOLECPATH INNOVATIONS ADVISORY GROUP

Scientists analyzing molecular and DNA structures using advanced technology.

EXECUTIVE ADVISORY FOR DIAGNOSTICS & PATHOLOGY

MolecPath helps investors, leadership teams and healthcare innovators make better decisions where commercial strategy, regulation, technology and adoption intersect.

DISCUSS A STRATEGIC DECISION

WHERE MOLECPATH GETS INVOLVED

Strategic Advisory at Critical Decision Points

Advisory & Board-Level Support

Independent perspective during capital raises, strategic pivots, partnerships, or acquisitions
Technical, regulatory, and commercialization diligence

Fractional Leadership

Interim leadership supporting commercialization, market expansion, or regulatory strategy
Hands-on support through transition periods without permanent headcount

Special Situations

Market entry, portfolio, or platform decisions where regulatory or adoption risk is high
Commercialization or partnership decisions where the stakes are high and evidence is incomplete

Focused advisory for decisions with real operating consequences — not generalized consulting.

WHAT MOLECPATH ADVISES ON

COMMERCIAL & MARKET STRATEGY

Market sizing, positioning, market entry, launch and adoption strategy, customer insight, and partnership decisions across diagnostics, pathology, AI, and regulated healthcare.

REGULATORY & ADOPTION ALIGNMENT

Align commercial decisions with regulatory requirements, validation needs, clinical workflow, evidence expectations, and implementation realities before they become expensive surprises.

EXECUTIVE & STRATEGIC ADVISORY

Independent decision support for boards, investors, founders, and leadership teams navigating diligence, portfolio choices, partnerships, market transitions, or other high-consequence decisions.

WHY MOLECPATH

MolecPath brings operating experience from regulated diagnostics and healthcare, where commercial decisions carry technical, regulatory, and financial consequences.

Senior leadership experience across diagnostics, molecular pathology, and digital pathology
Experience spanning regulated clinical environments, commercialization, market development, and AI-enabled technologies
Working knowledge of FDA, CLIA, CAP, and international regulatory frameworks
Advisory work with executives, investors, founders, and leadership teams on growth, adoption, partnerships, and risk

Grounded in operating experience, independent judgment, and decisions that must hold up outside the conference room.

START WITH THE DECISION

When the decision carries commercial, regulatory, or operating consequence, a focused conversation can help determine what needs to be tested, clarified, or challenged before resources are committed.

Bring the decision, the current assumptions, and what is at stake.

MolecPath will determine quickly whether independent advisory support can add value — and where it cannot.

Discuss a Strategic decision